// App-Quantinova.ai

2681 : Long-Term Prophylaxis with Simoctocog Alfa for the Management of Haemophilia Α: Immunogenicity, Efficacy and Safety Results from the Nuprotect PUP Extension Study

Researchers

Presenter

  • Ri J. Liesner

Principal Investigators

  • Ellis J. Neufeld

Medical Centers

  • Haemophilia Comprehensive Care Centre, Great Ormond Street Hospital for Children, London, United Kingdom

  • St. Jude Children's Research Hospital, Memphis, TN

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • rFVIII

  • simoctocog alfa

  • FVIII

  • Nuwiq

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01992549

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved